Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Sweden
/
Healthcare
Create a narrative
OssDsign Community
OM:OSSD Community
1
Narratives
written by author
0
Comments
on narratives written by author
4
Fair Values set
on narratives written by author
Create a narrative
OssDsign
Popular
Undervalued
Overvalued
Community Investing Ideas
OssDsign
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Pure Play Orthobiologics Will Expand US Healthcare Access
Key Takeaways Strategic shift to orthobiologics boosts growth and operational efficiency, enhancing future revenue and sustaining high net margins. U.S. market expansion and distinctive product benefits position OssDsign for significant market share and increased adoption.
View narrative
SEK 13.00
FV
1.8% undervalued
intrinsic discount
28.16%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
4 days ago
author updated this narrative
Your Valuation for
OSSD
OSSD
OssDsign
Your Fair Value
SEK
Current Price
SEK 12.76
57.5% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-130m
373m
2015
2018
2021
2024
2025
2027
2030
Revenue SEK 372.7m
Earnings SEK 55.0m
Advanced
Set Fair Value